Acute Myelogenous Leukemia
Showing NaN - NaN of 34
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia Trial in United States (drug,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Busulfan
- +11 more
-
Duarte, California
- +26 more
Aug 11, 2022
Acute Myelogenous Leukemia Trial in Australia, Canada, United States (Decitabine, Vorinostat, Filgrastim (G-CSF))
Completed
- Acute Myelogenous Leukemia
- Decitabine
- +4 more
-
Los Angeles, California
- +32 more
Jun 22, 2022
Acute Myelogenous Leukemia Trial in Atlanta, Boston, Madison (DC/AML Fusion Vaccine, Observation)
Recruiting
- Acute Myelogenous Leukemia
- DC/AML Fusion Vaccine
- Observation
-
Atlanta, Georgia
- +4 more
Apr 14, 2022
Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)
Active, not recruiting
- Acute Myelogenous Leukemia
- Myelodysplastic Syndrome
- Emavusertib
- +2 more
-
Tampa, Florida
- +8 more
Apr 5, 2022
Biology of Long-Term Late Effects Following Hematopoietic Cell
Active, not recruiting
- Acute Lymphoblastic Leukemia/Lymphoma
- +4 more
-
Scottsdale, Arizona
- +31 more
Mar 8, 2022
Acute Myelogenous Leukemia, AML Trial in Boston (DC AML Vaccine)
Active, not recruiting
- Acute Myelogenous Leukemia
- AML
- DC AML Vaccine
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jan 25, 2022
Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma Trial in United States (Haploidentical Bone Marrow
Completed
- Acute Lymphocytic Leukemia
- +6 more
- Haploidentical Bone Marrow Transplant
- Double Umbilical Cord Blood Transplant
-
Birmingham, Alabama
- +38 more
Nov 2, 2021
Acute Myelogenous Leukemia Trial in Boston (decitabine, DC/AML fusion cells)
Recruiting
- Acute Myelogenous Leukemia
- decitabine
- DC/AML fusion cells
-
Boston, Massachusetts
- +1 more
Nov 15, 2021
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia Trial in Australia, Canada, United States
Completed
- Acute Myelogenous Leukemia
- +4 more
- Single Umbilical Cord Blood Unit Transplant
- +6 more
-
Birmingham, Alabama
- +37 more
Oct 13, 2021
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)
Active, not recruiting
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
- MCLA-117 bispecific antibody
-
Augusta, Georgia
- +9 more
May 6, 2021
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Non-Hodgkin's Lymphoma Trial in United States (Infusion of one MPC
Completed
- Acute Myelogenous Leukemia
- +3 more
- Infusion of one MPC expanded cord unit and one unexpanded cord unit
- Infusion of two unexpanded cord blood units.
-
Miami, Florida
- +8 more
Jun 25, 2020
Acute Myelogenous Leukemia Trial in Boston (Brentuximab Vedotin, Mitoxantrone, Etoposide)
Completed
- Acute Myelogenous Leukemia
- Brentuximab Vedotin
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
Apr 12, 2020
Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma, Multiple Myeloma Trial in Boston (drug, radiation, biological)
Completed
- Non-Hodgkin's Lymphoma
- +4 more
- Fludarabine
- +3 more
-
Boston, Massachusetts
- +2 more
Dec 29, 2018
Acute Myeloid Leukemia, Acute Myelogenous Leukemia Trial in United States (Standard dose cytarabine for induction, SGN-CD33A,
Completed
- Acute Myeloid Leukemia
- Acute Myelogenous Leukemia
- Standard dose cytarabine for induction
- +3 more
-
Birmingham, Alabama
- +12 more
May 8, 2018
Acute Myeloid Leukemia (AML), Acute Myelocytic Leukemia, Acute Myelogenous Leukemia Trial in Boston (Lenalidomide,
Terminated
- Acute Myeloid Leukemia (AML)
- +4 more
- Lenalidomide
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Aug 15, 2017
Acute Myelogenous Leukemia Trial in Boston (Lenalidomide, Mitoxantrone, Etoposide)
Completed
- Acute Myelogenous Leukemia
- Lenalidomide
- +3 more
-
Boston, Massachusetts
- +2 more
Mar 15, 2016
Acute Myelogenous Leukemia, Diffuse Large B-Cell Leukemia, Chronic Lymphocytic Leukemia Trial in United States (BMS-936564
Completed
- Acute Myelogenous Leukemia
- +3 more
- BMS-936564 (Anti-CXCR4)
-
Birmingham, Alabama
- +10 more
Mar 5, 2015
Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in United States (clofarabine)
Completed
- Acute Myelogenous Leukemia
- Acute Myeloid Leukemia
-
Phoenix, Arizona
- +19 more
Mar 17, 2014
Acute Myelogenous Leukemia Trial in Worldwide (clofarabine (IV formulation), , cytarabine)
Completed
- Acute Myelogenous Leukemia
- clofarabine (IV formulation)
- +2 more
-
Scottsdale, Arizona
- +56 more
Mar 17, 2014
Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Relapsed Leukemia Trial in United States (clofarabine, Etoposide,
Completed
- Acute Lymphoblastic Leukemia
- +2 more
- clofarabine
- +2 more
-
Birmingham, Alabama
- +12 more
Mar 17, 2014
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in United States (MLN4924, Azacitidine)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Stanford, California
- +5 more
Dec 3, 2013